Context Therapeutics Inc. (CNTX) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CNTX Revenue Growth
CNTX Revenue Analysis (2019–2025)
As of May 8, 2026, Context Therapeutics Inc. (CNTX) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue.
Looking at the longer-term picture, CNTX's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including AGEN (+10.4% YoY), ONCO (-67.7% YoY), and TPVG. Compare CNTX vs AGEN →
CNTX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CNTXCurrent | $0 | - | - | - | |
 AGEN | $114M | +10.4% | +5.3% | -18.0% | |
 ONCO | $815,371 | -67.7% | - | -778.2% | |
 TPVG | $97M | - | - | 77.9% | |
 AGIO | $54M | +78.3% | - | -873.9% |
CNTX Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-124,657 | - | $-39,702,631 | - |
| 2024 | $0 | - | $0 | - | $-29,923,900 | - |
| 2023 | $0 | - | $0 | - | $-25,072,616 | - |
| 2022 | $0 | - | $0 | - | $-15,381,203 | - |
| 2021 | $0 | - | $0 | - | $-10,525,819 | - |
| 2020 | $0 | - | $0 | - | $-2,572,000 | - |
| 2019 | $0 | - | $0 | - | $-5,377,000 | - |
See CNTX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CNTX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CNTX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCNTX — Frequently Asked Questions
Quick answers to the most common questions about buying CNTX stock.
Is CNTX's revenue growth accelerating or slowing?
CNTX TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is CNTX's long-term revenue growth rate?
Context Therapeutics Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is CNTX's revenue distributed by segment?
CNTX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.